Peter J Mariani has bought stock on 2 days since Dec 2024

Peter J. Mariani is the Chief Financial Officer of CytoSorbents Corp (NASDAQ: CTSO), a medical device company focused on blood purification technologies for critical care and cardiac surgery patients.( He was appointed CFO effective August 14, 2024, bringing more than 25 years of financial leadership experience across high‑growth medical technology companies.( As CFO, he reports to CytoSorbents’ Chief Executive Officer and oversees the company’s financial strategy, capital allocation, and reporting. In June 2026, he demonstrated confidence in the company’s prospects by purchasing 100,000 shares of CytoSorbents common stock in an open‑market transaction, increasing his direct holdings to more than 600,000 shares when including restricted stock units.(

Before joining CytoSorbents, Mariani served as Executive Vice President and Chief Financial Officer of Axogen, Inc. (NASDAQ: AXGN), a medical technology company specializing in peripheral nerve repair, from 2016 through 2023.( Earlier in his career he held senior finance roles at other medical device companies, including a prior CFO role at Hansen Medical, Inc.( Mariani holds a Bachelor of Science in Accounting from Indiana University, providing the foundation for his long tenure as a strategic financial partner in the healthcare sector.(

Written by Perplexity from public sources.